นาสูความเปนเลิศ ทั้งในดานพาณิชยและคุณภาพผลิตภัณฑอยางเปนมืออาชพี” August 14, 2020 Subject: Clarification on the cause of changes in operating results. To: Director and Manager The Stock Exchange
Microsoft Word - I-!9%*#8˙I-*ˇ@( Blue Sky 20200929 EN_MDA Year End - Translation - 1 ACC-O-2010003 October 1, 2020 To: President The Stock Exchange of Thailand Subject: Management Discussion and
-1- AIT (VP-SEC) 012E/2021 May 6, 2021 Subject: Management's Discussion and Analysis of Operating Results for Q1-2021 To: The President of the Stock Exchange of Thailand Summary of Operations Q1–2021
Microsoft Word - NWR 030_E_Year19 (Translation) No.FN-NWR 030/2563 28 February 2020 Subject : Submission of Financial Statements for the Years ended 31 December 2019 To : President The Stock Exchange
238.24 million as at December 31, 2019 due to impairment of dead stock and could not to use.. • Intangible assets decreased from THB 172.47 million from December 31, 2018 to THB 1.79 million in December 31
Translation CEN 001-2020 March 2, 2020 Subject Management Discussion and Analysis for business operation of year 2019 To The Manager and President The Stock Exchange of Thailand Business operation as
decreasing in total revenue. • Inventories decreased from THB 369.33 million as at December 31, 2018 to THB 238.24 million as at December 31, 2019 due to impairment of dead stock. • Intangible assets decreased
, 2020 Subject Management’ Discussion and Analysis for the 1st Quarter in 2020 To Directors & Managers The Stock Exchange of Thailand Inter Pharma Public Company Limited (“the Company”) hereby submitting
March 31, 2020 To The President The Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Statements For three months ended March 31, 2020 Overall Group Performance Table
Rnj, (Translation) MD. 073/2020 May 13 , 2020 Re: Management Discussion and Analysis For the Operating Results ended March 31, 2020 To: President The Stock Exchange of Thailand Management Discussion